Search

Robert Tham Sjin

from Framingham, MA
Age ~54

Robert Sjin Phones & Addresses

  • Framingham, MA
  • Miramar, FL
  • Philadelphia, PA
  • Dorchester, MA
  • Orlando, FL

Work

Company: Avila therapeutics Jan 2010 Position: Scientist

Education

Degree: Ph.D. School / High School: University of Pennsylvania 1991 to 1998 Specialities: Biochemistry and Molecular Biophysics

Skills

Cell • Cancer • Assay Development • Cell Biology • Drug Discovery • In Vitro • In Vivo • Cell Based Assays • Project Leadership • Manager • Biotechnology • Cell Culture • Life Sciences • Molecular Biology • Drug Discovey

Industries

Biotechnology

Resumes

Resumes

Robert Sjin Photo 1

Director Discovery Biology

View page
Location:
Framingham, MA
Industry:
Biotechnology
Work:
Avila Therapeutics since Jan 2010
Scientist

Pervasis May 2009 - Jan 2010
Independent Consultant

Pervasis Therapeutics Jul 2005 - May 2009
Senior Scientist

Children's Hospital Boston Jan 2005 - Jul 2005
Instructor

Children's Hospital Boston 2001 - 2005
Post-doc
Education:
University of Pennsylvania 1991 - 1998
Ph.D., Biochemistry and Molecular Biophysics
University of Massachusetts, Amherst 1989 - 1991
BS, Biochemistry
Tallahassee Community College 1987 - 1989
AA
Skills:
Cell
Cancer
Assay Development
Cell Biology
Drug Discovery
In Vitro
In Vivo
Cell Based Assays
Project Leadership
Manager
Biotechnology
Cell Culture
Life Sciences
Molecular Biology
Drug Discovey

Publications

Us Patents

Anti-Angiogenic Peptides From The N-Terminus Of Endostatin

View page
US Patent:
20060251699, Nov 9, 2006
Filed:
Feb 28, 2006
Appl. No.:
11/364855
Inventors:
Judah Folkman - Brookline MA, US
Kashi Javaherian - Lexington MA, US
Robert Sjin - Framingham MA, US
Assignee:
Children's Medical Center Corporation - Boston MA
International Classification:
A61K 38/16
A61K 38/10
C07K 14/47
C07K 7/08
C07H 21/04
C12P 21/06
US Classification:
424423000, 514012000, 514013000, 514014000, 514015000, 530324000, 530325000, 530326000, 530327000, 530328000, 435069100, 435320100, 435325000, 536023500, 424641000
Abstract:
Provided herein are anti-angiogenic comprising the N-terminal end of endostatin, nucleic acids encoding the same, pharmaceutical preparations comprising an effective amount of the peptide and nucleic acids and use of the pharmaceuticals in treating or preventing diseases or conditions associated with undesirable angiogenesis.
Robert Tham Sjin from Framingham, MA, age ~54 Get Report